Literature DB >> 9766848

The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection.

D A Price1, U C Meier, P Klenerman, M A Purbhoo, R E Phillips, A K Sewell.   

Abstract

The propensity of HIV-1 for genetic variation, a consequence of error-prone reverse transcription combined with high rates of replication, is thought to contribute to the establishment of persistent infection in the host despite the presence of a vigorous antiviral immune response. Protective immunity to viruses is mediated primarily by cytotoxic T lymphocytes, which recognize viral peptides of 8-11 amino acids bound to major histocompatibility complex class I molecules on the surface of infected cells. In this review we examine the mechanisms by which mutation within peptide antigen-encoding regions of the viral genome enables HIV-1 to evade recognition by virus-specific cytotoxic T lymphocytes. The discussion is relevant to other genetically unstable viruses and more generally to intracellular pathogens of variable antigenicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766848     DOI: 10.1007/s001090050270

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  9 in total

1.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.

Authors:  Angel Varela-Rohena; Peter E Molloy; Steven M Dunn; Yi Li; Megan M Suhoski; Richard G Carroll; Anita Milicic; Tara Mahon; Deborah H Sutton; Bruno Laugel; Ruth Moysey; Brian J Cameron; Annelise Vuidepot; Marco A Purbhoo; David K Cole; Rodney E Phillips; Carl H June; Bent K Jakobsen; Andrew K Sewell; James L Riley
Journal:  Nat Med       Date:  2008-11-09       Impact factor: 53.440

6.  A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro.

Authors:  E G M Berkhoff; A C M Boon; N J Nieuwkoop; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Precise identification of a human immunodeficiency virus type 1 antigen processing mutant.

Authors:  Peter Zimbwa; Anita Milicic; John Frater; Thomas J Scriba; Antony Willis; Philip J R Goulder; Tilly Pillay; Huldrych Gunthard; Jonathan N Weber; Hua-Tang Zhang; Rodney E Phillips
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

8.  Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.

Authors:  Wan Ching Lim; Asif M Khan
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

9.  Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.

Authors:  Garry Dolton; Cristina Rius; Md Samiul Hasan; Aaron Wall; Barbara Szomolay; Enas Behiry; Thomas Whalley; Joel Southgate; Anna Fuller; Théo Morin; Katie Topley; Li Rong Tan; Philip J R Goulder; Owen B Spiller; Pierre J Rizkallah; Lucy C Jones; Thomas R Connor; Andrew K Sewell
Journal:  Cell       Date:  2022-07-14       Impact factor: 66.850

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.